跳至主要内容
临床试验/CTRI/2023/03/050569
CTRI/2023/03/050569尚未招募3 期

Inositols as an Adjuvant to Letrozole for Infertility in Polycystic Ovary Syndrome: A prospective, triple blinded Randomized control Pilot Trial- ILOP Trial - ILOP Trial

Priyanka Yoga P0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1The age of the patient is between 20 yrs to 35 yrs
  • 2Diagnosed as PCOS according to the Rotterdam criteria. (oligomenorrhoea hyperandrogenism (hirsutism, acne, or alopecia) or hyperandrogenemia (elevated levels of total or free T) and typical features of ovaries on ultrasound scan
  • 3A normal hysterosalpingogram or laparoscopy has been documented
  • 4Without any history of pelvic inflammatory disease or pelvic surgery
  • 5Normal uterine cavity
  • 6Male partners having semen analysis parameters within normal range, performed in preceding 6 months
  • 7Without any treatment history of exogenous gonadotropin or metformin.

排除标准

  • 1Endocrine factors like hyperprolactinemia, premature ovarian failure, hypothalamic amenorrhea or uncorrected thyroid disease.
  • 2Known cases of uncontrolled type 1 or 2 diabetes mellitus and/or hypertension.
  • 3Allergic reactions or presence of other contraindications for the use of letrozole or CC.
  • 4Other associated factors of infertility like a male factor, uterine factor or endometriosis.
  • 5Myo-inositol use < 3 months prior to study enrolment
  • 6Concomitant metformin use. Previous use is allowed with last use at least 6 weeks prior to randomization.

研究者

发起方
Priyanka Yoga P

相似试验